{"groups":[{"description":"Patients receiving umbilical cord blood for hematopoietic rescue following myeloablative conditioning\n\nUmbilical Cord Blood Transplantation After Myeloablative Conditioning: Fully-myeloablative Conditioning Regimen: cyclophosphamide (60mg/m2 days -6 \\& -5), fludarabine (25 mg/m2 days -7, -6, \\& -5) and total body irradiation (days -3, -2, \\& -1, total 1200 cGy) followed by cord blood infusion on day 0.","id":"FG000","title":"Myeloablative Conditioning"},{"description":"Patients receiving umbilical cord blood for hematopoietic rescue following non-myeloablative conditioning\n\nUmbilical Cord Blood Transplantation After Reduced-Intensity Conditioning: Reduced Intensity Conditioning Regimen: Extracorporeal Photopheresis (days -8 \\& -7), cyclophosphamide 50 mg/kg (day -6) pentostatin 4 mg/kg/d (continuous infusion days -5 \\& -4), total body irradiation (days -3 \\& -2, total 600cGy) followed by Umbilical Cord Blood Infusion day 0.","id":"FG001","title":"Reduced Intensity Conditioning"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"One subject signed consent but did not receive a transplant, so was dropped from the study and was not assigned to either arm."}